Cannakeys

Unlocking the Science of Cannabis

Cannabichromene (CBC) Cannabinoid Research

Cannabichromene (CBC) Research Dashboard

22

Primary Studies

18

Related Studies

40

Total Studies

Clinical Studies

0

Clinical Meta-analyses

0

Double-blind human trials

0

Clinical human trials

Pre-Clinical Studies

6

Meta-analyses/Reviews

4

Animal studies

11

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 40 studies associated with Cannabichromene (CBC).

Here is a small sampling of Cannabichromene (CBC) studies by title:

  • Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome
  • Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
  • Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
  • Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
  • Cannabis and Autoimmunity: Possible Mechanisms of Action

Components of the Cannabichromene (CBC) Research Dashboard

  • Top medical conditions associated with Cannabichromene (CBC)
  • Proven effects in clinical trials for Cannabichromene (CBC)
  • Receptors associated with Cannabichromene (CBC)
  • Individual study details for Cannabichromene (CBC)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Cannabichromene (CBC)

Description of Cannabichromene (CBC)

The plant-based (phytocannabinoid) CBC was discovered in 1966 (CBC-C5) and by 2016 there were a total of nine distinct members in the CBC family.

Other Names:

Cannabichromene

Cannabichromene (CBC) Properties and Effects

CBC displayed significant antidepressant-like effect in models of behavioral despair. CBC demonstrates potent antibacterial activity against MRSA. CBC is a stable cannabinoid, it has been found in century-old samples of cannabis. When thoroughly purified, natural CBC is racemic, and does not show any activity related to activation of CB1.

Cannabichromene (CBC) Receptor Binding

CBC is a potent activator of TRPA1.
Top  

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.